ASLAN Pharmaceuticals Announces Participation at Two Upcoming Virtual Investor Conferences
22 nov. 2021 07h00 HE
|
ASLAN PHARMACEUTICALS LIMITED
MENLO PARK, Calif. and SINGAPORE, Nov. 22, 2021 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (Nasdaq: ASLN), a clinical-stage, immunology-focused biopharmaceutical company developing innovative...
ASLAN Pharmaceuticals to Participate in Fireside Chat at the 12th Annual Jefferies London Healthcare Conference 2021
10 nov. 2021 07h00 HE
|
ASLAN PHARMACEUTICALS LIMITED
MENLO PARK, Calif. and SINGAPORE, Nov. 10, 2021 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (Nasdaq:ASLN), a clinical-stage immunology focused biopharmaceutical company developing innovative...
ASLAN Pharmaceuticals to Present at H.C. Wainwright 23rd Annual Global Investment Conference
09 sept. 2021 07h00 HE
|
ASLAN PHARMACEUTICALS LIMITED
MENLO PARK, Calif. and SINGAPORE, Sept. 09, 2021 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (Nasdaq:ASLN), a clinical-stage immunology focused biopharmaceutical company developing innovative...
ASLAN Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Corporate Update
06 août 2021 07h00 HE
|
ASLAN PHARMACEUTICALS LIMITED
Recruitment completed in June for the expansion cohort of the Multiple Ascending Dose (MAD) trial of ASLAN004, underway for the treatment of patients with moderate-to-severe atopic dermatitis Topline,...
ASLAN Pharmaceuticals to Participate in Fireside Chat at BTIG Virtual Biotechnology Conference
04 août 2021 07h00 HE
|
ASLAN PHARMACEUTICALS LIMITED
SINGAPORE, Aug. 04, 2021 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (Nasdaq:ASLN), a clinical-stage immunology focused biopharmaceutical company developing innovative treatments to transform the...
ASLAN Pharmaceuticals to Participate In Fireside Chat at Jefferies Virtual Healthcare Conference
25 mai 2021 07h30 HE
|
ASLAN PHARMACEUTICALS LIMITED
SINGAPORE, May 25, 2021 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (Nasdaq:ASLN), a clinical-stage immunology focused biopharmaceutical company developing innovative treatments to transform the lives...
ASLAN Pharmaceuticals Appoints Dr Kathleen Metters as Independent Director
18 mars 2021 07h27 HE
|
ASLAN PHARMACEUTICALS LIMITED
SINGAPORE, March 18, 2021 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (Nasdaq:ASLN), a clinical-stage immunology focused biopharmaceutical company developing innovative treatments to transform the...
ASLAN Pharmaceuticals Appoints Dr Neil Graham as Independent Director
18 févr. 2021 07h00 HE
|
ASLAN PHARMACEUTICALS LIMITED
SINGAPORE, Feb. 18, 2021 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (Nasdaq:ASLN), a clinical-stage immunology focused biopharmaceutical company developing innovative treatments to transform the...
Abstract on ASLAN Pharmaceuticals’ Varlitinib Accepted for Poster Presentation at ESMO Asia Congress 2019
10 sept. 2019 05h14 HE
|
ASLAN Pharmaceuticals Limited
SINGAPORE, Sept. 10, 2019 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (Nasdaq:ASLN, TPEx:6497), a clinical-stage oncology and immunology focused biopharma company, today announced that an abstract on...
ASLAN Pharmaceuticals Names Industry Veteran and Current Board Member Andrew Howden to Additional Role of Chairman
26 juil. 2019 04h20 HE
|
ASLAN Pharmaceuticals Limited
SINGAPORE, July 26, 2019 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (Nasdaq:ASLN, TPEx:6497), a clinical-stage oncology and immunology focused biopharma company, today announced that Andrew Howden...